Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Redundant and regulatory roles for Toll-like receptors in Leishmania infection.

Chauhan P, Shukla D, Chattopadhyay D, Saha B.

Clin Exp Immunol. 2017 Nov;190(2):167-186. doi: 10.1111/cei.13014. Epub 2017 Aug 7. Review.

PMID:
28708252
2.

CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.

Rocha-Perugini V, Martínez Del Hoyo G, González-Granado JM, Ramírez-Huesca M, Zorita V, Rubinstein E, Boucheix C, Sánchez-Madrid F.

Mol Cell Biol. 2017 Jul 14;37(15). pii: e00202-17. doi: 10.1128/MCB.00202-17. Print 2017 Aug 1.

3.

HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Seliger B, Kloor M, Ferrone S.

Oncoimmunology. 2017 Feb 6;6(2):e1171447. doi: 10.1080/2162402X.2016.1171447. eCollection 2017. Review.

4.

IL-2 Expression and T lymphocyte Phenotyping in Young Children Suffering from Upper Respiratory Tract Infection with Streptococcus Pyogenes.

Guadalupe Ramirez-Valles E, Dayali Gutierrez-Martinez V, Cervantes-Flores M, Ruiz-Baca E, Alvarado-Esquivel C.

Int J Biomed Sci. 2016 Jun;12(2):53-7.

5.

The Hierarchy of Antigen Delivery.

Garbi N, Kurts C.

EBioMedicine. 2016 Feb 18;5:7-8. doi: 10.1016/j.ebiom.2016.02.031. eCollection 2016 Mar. No abstract available.

6.

Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Moreira-Filho CA, Bando SY, Bertonha FB, Silva FN, Costa Lda F, Ferreira LR, Furlanetto G, Chacur P, Zerbini MC, Carneiro-Sampaio M.

Oncotarget. 2016 Feb 16;7(7):7497-533. doi: 10.18632/oncotarget.7120.

7.

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles.

McCullough KC, Milona P, Thomann-Harwood L, Démoulins T, Englezou P, Suter R, Ruggli N.

Vaccines (Basel). 2014 Oct 16;2(4):735-54. doi: 10.3390/vaccines2040735. Review.

8.

Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.

Cho KJ, Walseng E, Ishido S, Roche PA.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10449-54. doi: 10.1073/pnas.1507981112. Epub 2015 Aug 3.

9.

Molecular mechanism and cellular function of MHCII ubiquitination.

Oh J, Shin JS.

Immunol Rev. 2015 Jul;266(1):134-44. doi: 10.1111/imr.12303. Review.

10.

Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.

van Luijn MM, Kreft KL, Jongsma ML, Mes SW, Wierenga-Wolf AF, van Meurs M, Melief MJ, der Kant Rv, Janssen L, Janssen H, Tan R, Priatel JJ, Neefjes J, Laman JD, Hintzen RQ.

Brain. 2015 Jun;138(Pt 6):1531-47. doi: 10.1093/brain/awv080. Epub 2015 Mar 29.

11.

Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.

God JM, Cameron C, Figueroa J, Amria S, Hossain A, Kempkes B, Bornkamm GW, Stuart RK, Blum JS, Haque A.

J Immunol. 2015 Feb 15;194(4):1434-45. doi: 10.4049/jimmunol.1402382. Epub 2015 Jan 16.

12.

Cytomegalovirus immune evasion by perturbation of endosomal trafficking.

Lučin P, Mahmutefendić H, Blagojević Zagorac G, Ilić Tomaš M.

Cell Mol Immunol. 2015 Mar;12(2):154-69. doi: 10.1038/cmi.2014.85. Epub 2014 Sep 29. Review.

13.

Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation.

Seydoux E, Rothen-Rutishauser B, Nita IM, Balog S, Gazdhar A, Stumbles PA, Petri-Fink A, Blank F, von Garnier C.

Int J Nanomedicine. 2014 Aug 13;9:3885-902. doi: 10.2147/IJN.S64353. eCollection 2014.

14.

Understanding the biology of antigen cross-presentation for the design of vaccines against cancer.

Fehres CM, Unger WW, Garcia-Vallejo JJ, van Kooyk Y.

Front Immunol. 2014 Apr 8;5:149. doi: 10.3389/fimmu.2014.00149. eCollection 2014. Review.

15.

Presentation of phagocytosed antigens by MHC class I and II.

Mantegazza AR, Magalhaes JG, Amigorena S, Marks MS.

Traffic. 2013 Feb;14(2):135-52. doi: 10.1111/tra.12026. Epub 2012 Nov 29. Review.

16.

GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.

Phipps-Yonas H, Semik V, Hastings KT.

Eur J Immunol. 2013 Jan;43(1):65-74. doi: 10.1002/eji.201242379. Epub 2012 Nov 26.

17.

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.

van Luijn MM, Chamuleau ME, Ossenkoppele GJ, van de Loosdrecht AA, Marieke van Ham S.

Oncoimmunology. 2012 Mar 1;1(2):211-213.

18.

Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.

Wang J, Jin X, Liu J, Khosla C, Xia J.

Chem Asian J. 2012 May;7(5):992-9. doi: 10.1002/asia.201101041. Epub 2012 Mar 12.

19.

Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.

Zuo J, Thomas WA, Haigh TA, Fitzsimmons L, Long HM, Hislop AD, Taylor GS, Rowe M.

PLoS Pathog. 2011 Dec;7(12):e1002455. doi: 10.1371/journal.ppat.1002455. Epub 2011 Dec 22.

20.

Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment.

VanGuilder HD, Bixler GV, Brucklacher RM, Farley JA, Yan H, Warrington JP, Sonntag WE, Freeman WM.

J Neuroinflammation. 2011 Oct 11;8:138. doi: 10.1186/1742-2094-8-138.

Supplemental Content

Support Center